Patricia Carr serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Patricia Carr has executed 52 insider transactions totaling $4.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2019 involved selling 1,667 shares valued at $248.2K.
Patricia Carr currently holds 9,382 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patricia Carr has been a net seller of JAZZ stock. They have purchased $0 and sold $4.2M worth of shares.
Patricia Carr's most recent insider trade was on Dec 5, 2019, when they sold 1,667 shares at $148.89 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |